» Articles » PMID: 35814249

Yu-Ping-Feng Formula Ameliorates Alveolar-Capillary Barrier Injury Induced by Exhausted-Exercise Regulation of Cytoskeleton

Overview
Journal Front Pharmacol
Date 2022 Jul 11
PMID 35814249
Authors
Affiliations
Soon will be listed here.
Abstract

Yu-ping-feng powder (YPF) is a compound traditional Chinese medicine extensively used in China for respiratory diseases. However, the role of YPF in alveolar-capillary barrier dysfunction remains unknown. This study aimed to explore the effect and potential mechanism of YPF on alveolar-capillary barrier injury induced by exhausted exercise. Male Sprague-Dawley rats were used to establish an exhausted-exercise model by using a motorized rodent treadmill. YPF at doses of 2.18 g/kg was administrated by gavage before exercise training for 10 consecutive days. Food intake-weight/body weight, blood gas analysis, lung water percent content, BALF protein concentration, morphological observation, quantitative proteomics, real-time PCR, and Western blot were performed. A rat pulmonary microvascular endothelial cell line (PMVEC) subjected to hypoxia was applied for assessing the related mechanism. YPF attenuated the decrease of food intake weight/body weight, improved lung swelling and hemorrhage, alleviated the increase of lung water percent content and BALF protein concentration, and inhibited the impairment of lung morphology. In addition, YPF increased the expression of claudin 3, claudin 18, occludin, VE-cadherin, and β-catenin, attenuated the epithelial and endothelial hyperpermeability and/or , and the stress fiber formation in PMVECs after hypoxia. Quantitative proteomics discovered that the effect of YPF implicated the Siah2-ubiquitin-proteasomal pathway, Gng12-PAK1-MLCK, and RhoA/ROCK, which was further confirmed by Western blot. Data are available via ProteomeXchange with identifier PXD032737. YPF ameliorated alveolar-capillary barrier injury induced by exhausted exercise, which is accounted for at least partly by the regulation of cytoskeleton.

Citing Articles

An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine.

Hu S, Luo D, Zhu Q, Pan J, Chen B, Furian M Front Pharmacol. 2023; 14:1257345.

PMID: 38044944 PMC: 10693348. DOI: 10.3389/fphar.2023.1257345.


Effects of Yupingfeng Polysaccharides as Feed Supplement on Immune Function and Intestinal Microbiome in Chickens.

Zheng W, Guan Y, Wu B Microorganisms. 2023; 11(11).

PMID: 38004785 PMC: 10672924. DOI: 10.3390/microorganisms11112774.


Adjuvant treatment with yupingfeng granules for recurrent respiratory tract infections in children: A systematic review and meta-analysis.

Zhang L, Wang X, Wang D, Guo Y, Zhou X, Yu H Front Pediatr. 2023; 10:1005745.

PMID: 36619520 PMC: 9811950. DOI: 10.3389/fped.2022.1005745.

References
1.
Walton K, Dorne J, Renwick A . Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation. Food Chem Toxicol. 2001; 39(12):1175-90. DOI: 10.1016/s0278-6915(01)00088-6. View

2.
Zavorsky G . Evidence of pulmonary oedema triggered by exercise in healthy humans and detected with various imaging techniques. Acta Physiol (Oxf). 2007; 189(4):305-17. DOI: 10.1111/j.1748-1716.2006.01660.x. View

3.
Song T, Hou X, Yu X, Wang Z, Wang R, Li Y . Adjuvant Treatment with Yupingfeng Formula for Recurrent Respiratory Tract Infections in Children: A Meta-analysis of Randomized Controlled Trials. Phytother Res. 2016; 30(7):1095-103. DOI: 10.1002/ptr.5628. View

4.
Guo Y, Yin T, Wang X, Zhang F, Pan G, Lv H . Traditional uses, phytochemistry, pharmacology and toxicology of the genus Cimicifuga: A review. J Ethnopharmacol. 2017; 209:264-282. DOI: 10.1016/j.jep.2017.07.040. View

5.
Huang R, Cui Y, Wei X, Pan C, Li Q, He S . A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism. Am J Physiol Heart Circ Physiol. 2019; 316(6):H1378-H1388. DOI: 10.1152/ajpheart.00731.2018. View